InvestorsHub Logo
Followers 4
Posts 326
Boards Moderated 0
Alias Born 10/19/2005

Re: ALL-IN888 post# 23461

Wednesday, 12/19/2012 2:03:54 PM

Wednesday, December 19, 2012 2:03:54 PM

Post# of 130505
Like I said, sellers will regret it soon. I understand if you want to take profits...nothing wrong with that. But keep in mind a few things:

(1) Anything with a 90% similarity (homology) to MANF is considered to have the same characteristics that the AMBS patents cover. So if they alter GDNF during phase II trials and it has a similar structure then they have to talk to AMBS about licensing it. If anyone wants to alter CDNF or MANF during testing they have to talk to AMBS about licensing it. There is a reason Hermo Pharma challenged their patents and why the co-founder of Amgen said "MANF could be the biggest success I have ever seen."

(2) Right now MANF is producing much better results than GDNF produced at this stage and GDNF was purchased for over $250 Million AT THIS STAGE of testing. AMBS is only valued at $12 Million

You can try to get cute with flipping your shares but the moment a JV is announced you're not going to be able to get in. There is a reason the co-founder of Amgen is here. There is a reason senior executives of Bayer and Bristol Myers are here. They are not going to waste their time with something that they haven't done the research on.